Développement d'une stratégie thérapeutique pour la dystrophie facio-scapulo-humérale.

Abstract : FacioScapuloHumeral Dystrophy (FSHD) is a rare autosomal dominant neuromuscular disorder. This disease is caused by a loss of epigenetic marks within the D4Z4 macrosatellite located in the subtelomeric region of chromosome 4 leading to chromatin relaxation, aberrant expression of the DUX4 transcription factor and a cascade of gene deregulations. So far, there is no curative treatment for FSHD. The aim of this project was to determine whether or not targeting 3’-end key sequences involved in the polyadenylation of mRNA by antisens oligonucleotides (AOs) can be used as an efficient strategy for DUX4 gene silencing in FSHD. Indeed, cleavage and polyadenylation of the 3’-end of mRNAs are fundamental mechanisms of mRNAs maturation required for nuclear export, stability of the mRNAs and efficient translation and consequently could represent interesting targets for suppression of gene expression for gain of function diseases. For the first time, we demonstrated in vitro that targeting 3’-end key sequences involved in the addition of the poly(A) tail, such as the polyadenylation signal and the cleavage site, leads to an efficient extinction of the mRNA targeted and in particular DUX4. Because AOs have a weak cellular uptake and a rapid clearance in vivo, the sequences of the most promising AOs have been vectorised into an AAV vector under the control of the U7 promoter. The first results that we obtained with a FSHD mouse model treated with these vectors are promising. This innovating strategy appears as a therapeutic option for FSHD.
Document type :
Theses
Complete list of metadatas

Cited literature [840 references]  Display  Hide  Download

https://tel.archives-ouvertes.fr/tel-02151743
Contributor : Abes Star <>
Submitted on : Monday, June 10, 2019 - 1:01:14 AM
Last modification on : Monday, June 10, 2019 - 1:26:56 AM

File

2017PA066035.pdf
Version validated by the jury (STAR)

Identifiers

  • HAL Id : tel-02151743, version 1

Citation

Anne-Charlotte Marsollier. Développement d'une stratégie thérapeutique pour la dystrophie facio-scapulo-humérale.. Biologie cellulaire. Université Pierre et Marie Curie - Paris VI, 2017. Français. ⟨NNT : 2017PA066035⟩. ⟨tel-02151743⟩

Share

Metrics

Record views

196

Files downloads

75